Winton Capital »

Keros Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $440k 22k 20.36